Browse
related articles
Syria seizes drugs destined for Saudi Arabia
- Syria: Sunday, February 10 - 2008 at 12:50
Syrian customs authorities have seized hundreds of thousands of smuggled stimulant pills bound for Saudi Arabia, reported AP.More than 400,000 pills of the amphetamine-like drug Captagon hidden in bathroom tissue rolls were seized last month at a shipping company office in the northern city of Aleppo.The pills were bound for Saudi Arabia and a Syrian man from Aleppo who was involved was later arrested in the Syrian port city of Latakia. Captagon, also known as fenethylline, was listed by World Health Organization in 1986 as a pyschotropic substance, and is banned in most places and was once prescribed as an antidepressant or to treat hyperactive children.
Also consider reading:
Today's top stories
Week's top stories
Browse
related articles
- » Landmark Advisory's Developer Rating indicates deficit of Grade A developers in Dubai and Abu Dhabi
- » Starcom Mediavest Group continues award winning success at Mena Cristal Awards
- » New 2010 Hyundai Tucson expected to take UAE market by storm
- » Clemenceau Medical Center (CMC) amongst top ten world's best hospitals for medical tourism
- » ADAC, Al Jaber sign tenancy deal
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
Amena Bakr, Senior Reporter
